The Swiss bank’s wealth business is doing better than rivals, though investors should question its sustainability.
Moving out of food would raise questions as to how Kraft Heinz bid for Unilever would achieve the kind of savings investors have come to expect from a deal driven by 3G Capital.
The drug industry has had multiple expensive failures trying to treat Alzheimer’s disease, yet the big potential payoff keeps it searching.
Attempts by China’s regulators to stem the use of shadow financing tools by the nation’s lenders haven’t been working.
From Amazon.com to Donald Trump to Warren Buffett, Wal-Mart Stores faces an uphill battle as it reports fourth-quarter earnings.
Even at the lowball price Kraft Heinz has offered, buying soap-to-soup giant Unilever would stretch its balance sheet to its limits. But the U.S. food group needs a deal.
Applied Material saw a sharp jump in new equipment orders for the fiscal first quarter, its biggest surge in seven years. That has analysts worried about an inevitable slowdown, as Applied’s customers digest those purchases.
A striking feature of the U.S. stock market is that it persistently does better under Democratic presidents than Republican ones. Two economists try to explain why.
People often complain their insurers don’t pay out what they should: Investors in Allianz can have no such gripes.